Delivery Order SPE2DB22D1002-SPE2DB23FLGF7
- Not listed
- This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEBA8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product, with a ceiling value of $2,765.30 and a completion date of February 22, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
- This contract award, with a ceiling value of $2,788.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used for the treatment of opioid overdose. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November...
- This federal contract award, with the ID SPE2DB20D2104|SPE2DB24FU00X, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,665.40 delivery order contract is for the procurement of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has a firm fixed price pricing type and an ultimate completion date of May 6, 2024. This award is part of a larger Indefinite...
- This federal contract award to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The $2,772.75 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the...
- This federal contract award, valued at $1,203.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
- This federal contract award, with ID SPE2DB22D1002|SPE2DB24FKZE7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product, with a ceiling value of $2,120.19 and a completion date of March 13, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,657.60 firm fixed-price delivery order is for the procurement of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used for opioid overdose reversal. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $1,561.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,981.46 and is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award, valued at $5,486.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB23FLGF7Delivery Order
This federal contract award, with ID SPE2DB22D1002|SPE2DB23FLGF7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product, with a ceiling value of $5,852.16 and an ultimate completion date of September 15, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 9/14/23 |